Related Experiment Videos
[Steroid-responsive nephrotic syndrome in IgA nephropathy]
R M García Camín1, A Cabezas, F Calero
1Servicio de Nefrología, Fundación Puigvert, Barcelona, España. RMGarcía@fundacio-puigvert.es
Summary
This case study tracks a patient with nephrotic syndrome, initially diagnosed as minimal change disease, who later developed IgA nephropathy. Effective treatment involved steroids, cyclophosphamide, and cyclosporine, managing proteinuria and renal function.
Area of Science:
- Nephrology
- Immunology
- Internal Medicine
Background:
- A 46-year-old male with a history of smoking and alcohol consumption presented with nephrotic syndrome.
- Initial presentation included severe hypoalbuminemia and heavy proteinuria, with normal renal function.
Observation:
- The first renal biopsy revealed minimal change disease, which responded well to steroid therapy.
- Subsequent biopsies showed a progression to IgA nephropathy, necessitating more aggressive immunosuppressive treatment.
Findings:
- The patient experienced multiple relapses of nephrotic syndrome, demonstrating steroid-responsiveness initially.
- Combination therapy with steroids, cyclophosphamide, and later cyclosporine was crucial in managing proteinuria and stabilizing renal function.
- Despite disease progression, long-term management achieved proteinuria levels of 1.6 g/d and preserved renal function (C. creat. 59 ml/min).
Implications:
- This case highlights the diagnostic challenge and evolving treatment strategies for nephrotic syndrome with changing histopathology.
- It underscores the importance of long-term monitoring and multi-drug regimens in managing complex IgA nephropathy.
- The successful use of cyclosporine suggests its potential role in refractory cases of IgA nephropathy with nephrotic syndrome.